Lilly and Merck announced a new study combining Lartruvo and Keytruda:
https://investor.lilly.com/releasedetail.cfm?ReleaseID=1007544
The study combining Olaratumab (Lartruvo) and Pembrolizumab (Keytruda) can be found here:
Lilly and Merck announced a new study combining Lartruvo and Keytruda:
https://investor.lilly.com/releasedetail.cfm?ReleaseID=1007544
The study combining Olaratumab (Lartruvo) and Pembrolizumab (Keytruda) can be found here: